| |
Validated group
|
Elderly group
|
p value
|
|---|
|
n
|
mean ± SD
|
n
|
mean ± SD
|
|---|
|
Age (year)
|
M
|
46
|
69.85 ± 7.03
|
419
|
69.10 ± 6.59
|
0.267
|
| |
F
|
47
|
67.89 ± 6.11
|
435
|
68.52 ± 6.44
|
0.524
|
|
Height (cm)
|
M
|
43
|
163.85 ± 6.30
|
419
|
164.14 ± 6.16
|
0.770
|
| |
F
|
47
|
153.00 ± 5.76
|
435
|
152.56 ± 5.99
|
0.636
|
|
Weight (kg)
|
M
|
43
|
67.14 ± 10.70
|
419
|
64.01 ± 9.16
|
0.037
|
| |
F
|
47
|
55.32 ± 7.70
|
435
|
56.02 ± 8.64
|
0.594
|
|
BMI (kg/m2)
|
M
|
43
|
24.93 ± 3.11
|
419
|
23.72 ± 2.83
|
0.009
|
| |
F
|
47
|
23.66 ± 3.28
|
435
|
24.04 ± 3.25
|
0.451
|
|
GS (m/s)
|
M
|
43
|
1.07 ± 0.19
|
418
|
1.08 ± 0.20
|
0.827
|
| |
F
|
47
|
1.03 ± 0.15
|
435
|
1.02 ± 0.18
|
0.708
|
|
HS (kg)
|
M
|
43
|
35.50 ± 7.38
|
419
|
36.58 ± 7.08
|
0.346
|
| |
F
|
47
|
23.29 ± 4.12
|
435
|
23.47 ± 4.58
|
0.792
|
|
ASM (kg)
| | | | | | |
|
BIA
|
M
|
43
|
19.72 ± 2.85
|
419
|
19.63 ± 2.95
|
0.830
|
| |
F
|
47
|
13.86 ± 2.25
|
435
|
14.02 ± 2.36
|
0.667
|
|
DEXA
|
M
|
43
|
18.74 ± 3.16
|
0
|
*
| |
| |
F
|
47
|
13.37 ± 2.13
|
0
|
*
| |
|
ASMI (kg/m2)
| | | | | | |
|
BIA
|
M
|
43
|
7.32 ± 0.69
|
419
|
7.26 ± 0.75
|
0.591
|
| |
F
|
47
|
5.89 ± 0.66
|
435
|
5.99 ± 0.72
|
0.379
|
|
DEXA
|
M
|
43
|
6.95 ± 0.87
|
0
|
*
| |
| |
F
|
47
|
5.70 ± 0.77
|
0
|
*
| |
|
Medical diagnoses
| | | | | | |
|
Hypertension
|
M
|
43
|
19 (44.2)
|
419
|
178 (42.5)
|
0.830
|
| |
F
|
47
|
18 (38.3)
|
435
|
196 (45.2)
|
0.368
|
|
Diabetes
|
M
|
43
|
6 (14.0)
|
419
|
82 (19.6)
|
0.372
|
| |
F
|
47
|
10 (21.3)
|
435
|
82 (18.9)
|
0.688
|
|
Thyroid diseases
|
M
|
43
|
0
|
419
|
2 (0.5)
|
1.000
|
| |
F
|
47
|
0
|
435
|
4 (0.9)
|
1.000
|
|
Cardiac diseases
|
M
|
43
|
1 (2.3)
|
419
|
23 (5.5)
|
0.373
|
| |
F
|
47
|
7 (14.9)
|
435
|
20 (4.6)
|
0.004
|
|
Renal diseases
|
M
|
43
|
0
|
419
|
6 (1.4)
|
1.000
|
| |
F
|
47
|
2 (4.3)
|
435
|
7 (1.6)
|
0.216
|
|
Stroke
|
M
|
43
|
0
|
418
|
4 (1.0)
|
1.000
|
| |
F
|
47
|
0
|
434
|
5 (1.2)
|
1.000
|
|
Cancer
|
M
|
43
|
1 (2.3)
|
419
|
3 (0.7)
|
0.324
|
| |
F
|
47
|
0
|
435
|
2 (0.5)
|
1.000
|
|
COPD
|
M
|
43
|
0
|
419
|
5 (1.2)
|
1.000
|
| |
F
|
47
|
1 (2.1)
|
435
|
7 (1.6)
|
0.563
|
|
Tuberculosis
|
M
|
43
|
0
|
419
|
9 (2.1)
|
1.000
|
| |
F
|
47
|
0
|
435
|
1 (0.2)
|
1.000
|
|
Hepatic diseases
|
M
|
43
|
1 (2.3)
|
419
|
8 (1.9)
|
0.588
|
| |
F
|
47
|
0
|
435
|
7 (1.6)
|
1.000
|
|
Smoking habits
|
M
|
43
|
12 (27.9)
|
419
|
118 (28.2)
|
0.972
|
| |
F
|
47
|
0
|
435
|
13 (3.0)
|
0.626
|
|
Alcohol consumption
|
M
|
43
|
24 (55.8)
|
419
|
173 (41.3)
|
0.067
|
| |
F
|
47
|
12 (25.5)
|
435
|
48 (11.1)
|
0.004
|
- *: no data; BMI body mass index, GS gait speed, HS handgrip strength, ASM appendicular skeletal muscle mass, ASMI appendicular skeletal muscle mass index, BIA bioelectrical impedance analysis, DXA dual energy x-ray absorptiometry, COPD chronic obstructive pulmonary disease; Using independent-samples t test for continuous variables and Pearson chi-square or Fisher exact test (where an expected cell count was < 5) for categorical variables. During testing, p < 0.05 was considered statistically significant
